Table 8.
| Recombinant enzyme deficient | Drug name | Dosage (mg/kg of body weight) once a week |
|---|---|---|
| Larondiase | Aldurazyme | 0.58 mg/kg |
| Idursulfase | Elaprase | 0.5 mg/kg |
| Elosulfase alfa | Vimizim | 2 mg/kg |
| Galsulfase | Naglazyme | 1 mg/kg |
| Vestronidase alfa | Mepsevii | 4 mg/kg bi-weekly |
Note; Compared with other countries, the overall annual cost for ERT differs slightly depending on the country, for example, the cost of ERT annually in Japan for a 25 kg MPS II patient is $400,000 [13].